ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,097,724 | -48.7% | 977,200 | -19.6% | 0.01% | -46.7% |
Q2 2023 | $6,037,059 | -5.6% | 1,214,700 | -6.2% | 0.02% | -6.2% |
Q1 2023 | $6,396,312 | +5.9% | 1,294,800 | +34.8% | 0.02% | -5.9% |
Q4 2022 | $6,040,916 | +151.4% | 960,400 | +331.6% | 0.02% | +142.9% |
Q3 2022 | $2,403,000 | +59.0% | 222,500 | +67.9% | 0.01% | +75.0% |
Q2 2022 | $1,511,000 | -28.7% | 132,500 | -43.0% | 0.00% | -33.3% |
Q1 2022 | $2,118,000 | +19.8% | 232,500 | +242.9% | 0.01% | +20.0% |
Q2 2021 | $1,768,000 | -87.9% | 67,800 | -83.6% | 0.01% | -87.5% |
Q1 2021 | $14,618,000 | +64.6% | 414,100 | +17.7% | 0.04% | +66.7% |
Q4 2020 | $8,879,000 | -30.2% | 351,800 | +4.2% | 0.02% | -33.3% |
Q3 2020 | $12,727,000 | +822.9% | 337,500 | +948.1% | 0.04% | +800.0% |
Q2 2020 | $1,379,000 | – | 32,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
Navalign, LLC | 64,428 | $961,000 | 0.38% |
Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |